EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access

Evaluating Automated Tools for Lesion Detection on 18 F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast Cancer

Renee Miller iD, Mark Battle, Kristen Wangerin, Daniel T Huff, Amy J Weisman, Song Chen iD, Timothy G Perk, Gary A Ulaner iD

Radiology: Imaging Cancer · 2025

DOI: 10.1148/rycan.240253 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Radiology: Imaging Cancer, 2025. Verfasst von Renee Miller und 7 weiteren Autor:innen. Beteiligte Einrichtung: GE HealthCare, Pollards Wood, Nightingales Lane, Chalfont Saint Giles HP8 4SP, United Kingdom. Hauptthemen laut MEDLINE: Breast Neoplasms, Estradiol, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An artificial intelligence model was trained to detect lesions on fluorine 18 ( 18 F)-fluoroestradiol (FES) PET/CT images and an automated concordance tool measured heterogeneity between 18 F-FES PET/CT and standard-of-care imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEstradiolPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMiddle AgedFluorine RadioisotopesFluorodeoxyglucose F18Prospective StudiesRadiopharmaceuticalsRetrospective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

18F-FES PETArtificial IntelligenceBreastComputer Applications-General (Informatics)Lesion DetectionLesion MatchingMetastatic Breast CancerMolecular Imaging-CancerNeural NetworksPET/CTSegmentation

Substanzen

16-fluoroestradiolEstradiolFluorine RadioisotopesFluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • GE HealthCare, Pollards Wood, Nightingales Lane, Chalfont Saint Giles HP8 4SP, United Kingdom.
  • AIQ Solutions, Madison, Wis.
  • Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, China.
  • Department of Molecular Imaging and Therapy, Hoag Family Cancer Institute, Irvine, Calif.
  • Department of Radiology and Translational Genomics, University of Southern California, Los Angeles, Calif.

ORCID-Profile: Renee Miller, Song Chen, Gary A Ulaner

Zitieren

APA

Miller, R., Battle, M., Wangerin, K., Huff, D. T., Weisman, A. J., Chen, S., Perk, T. G., & Ulaner, G. A. (2025). Evaluating Automated Tools for Lesion Detection on 18 F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast Cancer. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240253

Vancouver

Miller R, Battle M, Wangerin K, Huff DT, Weisman AJ, Chen S, et al. Evaluating Automated Tools for Lesion Detection on 18 F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast Cancer. Radiology: Imaging Cancer. 2025. doi:10.1148/rycan.240253

BibTeX
@article{Miller2025,
  author = {Miller, Renee and Battle, Mark and Wangerin, Kristen and Huff, Daniel T and Weisman, Amy J and Chen, Song and Perk, Timothy G and Ulaner, Gary A},
  title = {Evaluating Automated Tools for Lesion Detection on 18 F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast Cancer},
  journal = {Radiology: Imaging Cancer},
  year = {2025},
  doi = {10.1148/rycan.240253}
}
Kostenlos starten →